PAHC Phibro Animal Health Corporation
PAHC Phibro Animal Health Corporation
Healthcare · Drug Manufacturers - Specialty & Generic
Desk view
Market read
Scan convergence 2 scans as of 2026-10-16 2 neutral converging
POC $35.54 · VWAP $41.48 · -6.4% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 related campaign
PAHC Price Structure
Loading timeframes…
Peers
Every watchlist PAHC belongs to, members best 30-day change first — PAHC highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@livestock-disease
Reported EPS $0.85 versus analyst consensus of $0.73 (+17.1%).
full note →Against street estimates
How PAHC's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about PAHC from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 2 days ago · Oct 15
- Phibro Animal Health Corporation - Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance
- Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance – Company Announcement - FT.com
- Phibro Animal Health Corporation (PAHC) Stock Price, News, Quote & History - Yahoo Finance
- Phibro Animal Health Corporation - Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance
- PAHC Stock Climbs As Earnings Beat Fuels Animal Health Momentum
PAHC research tape
24 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.